Search - Prime Therapeutics

366 Results for GLP-1 Pipeline Update

Biosimilars

Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...
High Cost Therapy Profile: January 2025

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...
Prime’s SIU team tracking the rise of drug-related schemes on social media

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Prime Article: Perspectives
Expert Clinical Network Insights: December 2024

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...